<DOC>
	<DOCNO>NCT00219401</DOCNO>
	<brief_summary>The National Health Plan 2001-2010 call investigation feasibility pneumococcal vaccine Papau New Guinea . The Papua New Guinea ( PNG ) Institute Medical Research , Telethon Institute Child Health Research Department Paediatrics , University Western Australia collaborate examine closely safety neonatal vaccination , particularly regard impact development immunity response vaccine give infant . This study also provide unique opportunity training PNG Australian scientist country .</brief_summary>
	<brief_title>Neonatal Immunization With Pneumococcal Conjugate Vaccine Papua New Guinea</brief_title>
	<detailed_description>In order obtain early possible protection invasive pneumococcal disease , achieve optimal coverage reduce burden early carriage , neonatal pneumococcal conjugate vaccine ( PCV ) immunization need consider . This study PNG highlands enrol 312 infant birth , randomise receive PCV either 1-2-3 month ( infant schedule accord PNG national EPI schedule ) 0-1-2 month age ( neonatal schedule ) receive routine immunization ( control ) . Blood sample take birth-2-3-4 month age , pre- post-pneumococcal polysaccharide booster ( 23vPPV ) 9-10 month age ( assess immune memory ) 18 month study completion . Carriage assess weekly first month life regular interval thereafter . There ongoing surveillance respiratory disease throughout study . In addition serotype-specific IgG , examine IgG avidity , IgG subclasses , mucosal IgA T-cell cytokine response PCV pneumococcal protein antigen . To ensure immunological safety , particularly neonatal PCV , immune response concomitant vaccine viral environmental antigen also examine well overall T-cell maturation .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>New born baby birth weight &gt; 2000 g ( 2 kg ) parent give consent 1 . Acute neonatal infection ; 2 . Severe congenital abnormality ; 3 . Children mother know HIV positive exclude ; 4 . Serious asphyxia birth ; 5 . Intended migration next 2 year ; 6 . Parents withdraw consent ;</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Pneumococcal vaccine</keyword>
	<keyword>Antibody response</keyword>
	<keyword>Cellular immunology</keyword>
	<keyword>Th1/Th2 immune response</keyword>
	<keyword>Paediatric</keyword>
	<keyword>Neonatal</keyword>
	<keyword>Infectious disease</keyword>
	<keyword>Papua New Guinea</keyword>
</DOC>